ASPECT BIOSYSTEMS
Summary
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 92 M
Avg. Deal Size£ 92 M
All rights reserved. Copyright © 2025 Datasite
Summary
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
Senior Management
Tamer Mohamed
Founder and CEO
Natalie Korenic
Chief of Staff to the CEO & Sr. Director, Communications